ASPE Aspen Neuroscience, Inc.
Healthcare · Pharmaceutical Preparations · Market cap: not available
–
Bought and sold by quarter, last 5 years
Open-market purchases and sales by this company's insiders, in dollars, last 5 years
| Quarter | Bought | Sold |
|---|---|---|
| 2022-Q1 | $0 | $0 |
| 2022-Q2 | $0 | $0 |
| 2022-Q3 | $0 | $0 |
| 2022-Q4 | $0 | $0 |
| 2023-Q1 | $0 | $0 |
| 2023-Q2 | $0 | $0 |
| 2023-Q3 | $0 | $0 |
| 2023-Q4 | $0 | $0 |
| 2024-Q1 | $0 | $0 |
| 2024-Q2 | $0 | $0 |
| 2024-Q3 | $0 | $0 |
| 2024-Q4 | $0 | $0 |
| 2025-Q1 | $0 | $0 |
| 2025-Q2 | $0 | $0 |
| 2025-Q3 | $0 | $0 |
| 2025-Q4 | $0 | $0 |
| 2026-Q1 | $0 | $0 |
| 2026-Q2 | $0 | $0 |
| 2026-Q3 | $0 | $0 |
| 2026-Q4 | $68.0M | $0 |
Bought$68.0M4 buy days
Sold$00 sell days
Net insider flow+$68.0Mnet buying · 5 years
Latest trade2026-11-02CRANDELL KEITH
| Date | Side | Insider | Role | Shares | Avg price | Value | Trades |
|---|---|---|---|---|---|---|---|
| 2026-11-02 | Buy | CRANDELL KEITH | 10% owner | 1,333,333 | $15.00 | $20.0M | 3 |
| 2026-11-02 | Buy | BERNS PAUL L | 10% owner | 1,200,000 | $15.00 | $18.0M | 1 |
| 2026-11-02 | Buy | Thompson Peter A. | Director | 1,000,000 | $15.00 | $15.0M | 1 |
| 2026-11-02 | Buy | ORBIMED ADVISORS LLC | Director | 1,000,000 | $15.00 | $15.0M | 1 |
Who the insiders are, last 5 years
Everyone who bought or sold this company's shares on the open market in the last 5 years, biggest first.
| Insider | Role | Bought | Sold | Last trade |
|---|---|---|---|---|
| CRANDELL KEITH | 10% owner | $20.0M | $0 | 2026-11-02 |
| BERNS PAUL L | 10% owner | $18.0M | $0 | 2026-11-02 |
| ORBIMED ADVISORS LLC | Director | $15.0M | $0 | 2026-11-02 |
| Thompson Peter A. | Director | $15.0M | $0 | 2026-11-02 |
Past buying clusters
A cluster is a run of purchases by three or more insiders. Returns are the stock's return minus its benchmark's (IWM for small companies, SPY otherwise), from the first open after the run became a cluster. Past results, not a forecast.
| Window | Insiders | Total | Score | 21 days vs benchmark | 63 days vs benchmark | 126 days vs benchmark | Status |
|---|---|---|---|---|---|---|---|
| 2026-11-02 | 4 | $68.0M | 48 | – | – | – | active |
Yahoo Finance data, delayed, loaded through this server. Informational only; not investment advice.